Mucinous cystadenocarcinoma natural history: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 10: Line 10:
==Prognosis==
==Prognosis==
* Advanced stages of mucinous cystadenocarcinoma have inferior prognosis.  
* Advanced stages of mucinous cystadenocarcinoma have inferior prognosis.  
* MCACL has a much more favorable prognosis than most other forms of adenocarcinoma and most other NSCLC's.[9][14] Cases have been documented of continued growth of these lesions over a period of 10 years without symptoms or metastasis. The overall mortality rate appears to be somewhere in the vicinity of 18% to 27%, depending on the criteria that are used to define this entity.
* Mucinous cystadenocarcinoma has a much more favorable prognosis than most other forms of adenocarcinoma. Cases have been documented of continued growth of these lesions over a period of 10 years without symptoms or metastasis. The overall mortality rate appears to be somewhere in the vicinity of 18% to 27%, depending on the criteria that are used to define this entity.


==References==
==References==

Revision as of 15:24, 25 February 2016

Mucinous cystadenocarcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mucinous Cystadenocarcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucinous cystadenocarcinoma natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucinous cystadenocarcinoma natural history

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucinous cystadenocarcinoma natural history

CDC on Mucinous cystadenocarcinoma natural history

Mucinous cystadenocarcinoma natural history in the news

Blogs on Mucinous cystadenocarcinoma natural history

Directions to Hospitals Treating Mucinous cystadenocarcinoma

Risk calculators and risk factors for Mucinous cystadenocarcinoma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Natural History

  • If left untreated, most of patients with mucinous cytoadenocarcinoma may be confined to the organ itself. Some of them may develop metastasis to gastrointestinal tract.[1]

Complications

  • Metastasis

Prognosis

  • Advanced stages of mucinous cystadenocarcinoma have inferior prognosis.
  • Mucinous cystadenocarcinoma has a much more favorable prognosis than most other forms of adenocarcinoma. Cases have been documented of continued growth of these lesions over a period of 10 years without symptoms or metastasis. The overall mortality rate appears to be somewhere in the vicinity of 18% to 27%, depending on the criteria that are used to define this entity.

References

  1. Guruprasad, Bhat (2012). "Mucinous cystadenocarcinoma of ovary: Changing treatment paradigms". World Journal of Obstetrics and Gynecology. 1 (4): 42. doi:10.5317/wjog.v1.i4.42. ISSN 2218-6220.

Template:WH Template:WS